Marvell stock price target cut to $90 by Susquehanna

Susquehanna maintained a Positive rating on Marvell (MRVL) but lowered the price target to $90 from $110, citing competitive pressures and variability in T2 volume deployment despite strong AI demand and hyperscaler investment in data centers; the firm expects Marvell's upcoming earnings to be in line with guidance, while analysts project significant sales growth this year, with revenue projected to grow by 42%, reflecting a mixed sentiment amid positive outlooks from JPMorgan and Stifel and a downgrade from Melius Research.

Analysis

Susquehanna has maintained a Positive rating on Marvell Technology (MRVL) but significantly reduced its price target from $110 to $90, reflecting concerns over competitive pressures in its Inphi and custom ASIC segments, and variability in Trainium2 volume deployment, despite the stock trading at $60.69 and having declined approximately 45% year-to-date. While Marvell's upcoming earnings on May 29, 2025, are anticipated to align with guidance, and April quarter revenue was reaffirmed at $1.875 billion (seen as underwhelming by some), the company faces a nuanced outlook. Strong underlying demand in data centers driven by AI investment is a tailwind for Marvell’s Inphi PAM4 DSPs and custom AI products; however, challenges include potentially lower-than-expected Trainium2 average selling prices, modest near-term data center growth from key customers like Amazon, limited visibility on Trainium2 production beyond one or two quarters, and escalating competition from Broadcom, Nvidia, and others in the 3nm space. The postponement of its Investor Day, replaced by a focused webinar on AI custom silicon, adds to investor uncertainty, though InvestingPro data indicates a "Fair" financial health (2.0/5) with strong cash flow and projects a significant 42% revenue growth for the year, with AI ASIC and networking revenues estimated at $4 billion. While segments like cloud storage, carrier infrastructure, and enterprise networking show promise, consumer segment performance has been weak, and gross margins may face near-term pressure from the custom silicon ramp-up. Analyst sentiment is mixed, with JPMorgan and Stifel maintaining positive ratings, Melius Research downgrading to Hold, and Morgan Stanley remaining Equalweight, though a strong overall consensus rating (1.51) and InvestingPro's assessment of slight undervaluation suggest underlying optimism despite current headwinds.

Key Decisions for Investors

• Investors should scrutinize Marvell's upcoming earnings on May 29, 2025, July quarter guidance (projected above $2 billion), and the forthcoming custom AI silicon webinar for clarity on growth trajectory, strategic positioning, and execution in key AI-driven segments.
• Closely monitor Marvell's Trainium2 deployment volumes and average selling prices, alongside the intensifying competitive pressures from Broadcom, Nvidia, and others, as these are critical determinants for achieving the projected 42% annual revenue growth and navigating margin pressures.
• Given the significant 45% year-to-date stock decline, mixed analyst sentiment, and InvestingPro's indication of slight undervaluation against a backdrop of strong long-term AI demand, investors should carefully weigh the potential for recovery against near-term operational uncertainties and competitive risks before adjusting positions.